Control of virus-induced lymphoproliferation: Epstein-Barr virus-induced lymphoproliferation and host immunity

This publication has 33 references indexed in Scilit:

• Inhibition of antigen processing by the internal repeat region of the Epstein–Barr virus nuclear antigen-1
  Nature, 1995
• HLA-A0201 and HLA-B7 binding peptides in the EBV-encoded EBNA-1, EBNA-2 and BZLF-1 proteins detected in the MHC class I stabilization assay. Low proportion of binding motifs for several HLA class I alleles in EBNA-1
  International Immunology, 1995
• Epstein-Barr virus strategy in normal and neoplastic B cells
  Cell, 1994
• Endoplasmic reticulum signal sequence facilitated transport of peptide epitopes restores immunogenicity of an antigen processing defective tumour cell line
  International Immunology, 1994
• Epstein-Barr Virus Infections: Biology, Pathogenesis, and Management
  Annals of Internal Medicine, 1993
• Immune escape by Epstein-Barr virus (EBV) carrying Burkitt's lymphoma: in vitro reconstitution of sensitivity to EBV-specific cytotoxic T cells
  International Immunology, 1992
• Identification of target antigens for the human cytotoxic T cell response to Epstein-Barr virus (EBV): implications for the immune control of EBV-positive malignancies.
  The Journal of Experimental Medicine, 1992
• Interleukin 10 (IL-10) and viral IL-10 strongly reduce antigen-specific human T cell proliferation by diminishing the antigen-presenting capacity of monocytes via downregulation of class II major histocompatibility complex expression.
  The Journal of Experimental Medicine, 1991
• Downregulation of cell adhesion molecules LFA-3 and ICAM-1 in Epstein-Barr virus-positive Burkitt's lymphoma underlies tumor cell escape from virus-specific T cell surveillance.
  The Journal of Experimental Medicine, 1988
• Epstein–Barr virus-positive Burkitt's lymphoma cells not recognized by virus-specific T-cell surveillance
  Nature, 1985